Loading...
Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials
Pharmacogenetics and biomarkers are becoming normalised as important technologies to improve drug efficacy rates, reduce the incidence of adverse drug reactions, and make informed choices for targeted therapies. However, their wider clinical implementation has been limited by a lack of robust eviden...
Na minha lista:
| Udgivet i: | J Pers Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6789450/ https://ncbi.nlm.nih.gov/pubmed/31480618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm9030042 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|